Meeting Purpose
Patients with Chronic Kidney Diseases (CKDs) frequently experience disturbances of mineral metabolism resulting in systemic effects on the blood, bone, and vasculature. Iron and phosphate are important to maintain these systems; however, the biological signals controlling their regulation are only partly understood. Fibroblast Growth Factor 23 (FGF-23), a bone-derived hormone, regulates systemic phosphate homeostasis. Its discovery also has revealed novel interactions between phosphate and iron homeostasis. The NIDDK extramural research community offers a wealth of existing resources, infrastructure, and expertise that could accelerate the progress in this developing research area. Interdisciplinary approaches to understanding the physiologic and molecular regulators of phosphate and iron among patients with CKDs may identify novel diagnostic tools, new interventions, and improve clinical outcomes.
Organizing Committee
External Organizers
Tomas Ganz, M.D., Ph.D.; University of California, Los Angeles
Alan Go, M.D.; Kaiser Permanente Division of Research
Sharon Moe, M.D.; Indiana University
Orson Moe, M.D.; University of Texas Southwestern Medical Center
Isidro Salusky, M.D.; University of California, Los Angeles
Myles Wolf, M.D.; Duke University
NIH Organizers
Kevin Abbott, M.D., M.P.H.; NIDDK/KUH
Bonnie Burgess-Beusse, Ph.D.; NIDDK/DDN
Faye Chen, Ph.D.; NIAMS/DMD
Michael Flessner, M.D., Ph.D.; NIDDK/KUH
Daniel Gossett, Ph.D.; NIDDK/KUH
Chris Ketchum, Ph.D.; NIDDK/KUH
Paul Kimmel, M.D.; NIDDK/KUH
John Kusek, Ph.D.; NIDDK/KUH
Saul Malozowski, M.D., Ph.D., M.B.A.; NIDDK/DEM
Marva Moxey-Mims, M.D.; NIDDK/KUH
Cindy Roy, Ph.D.; NIDDK/KUH
Krystyna Rys-Sikora, Ph.D.; NIDDK/KUH
Jason Wan, Ph.D.; NIDCR/IBIDB
John Williams, Ph.D.; NIA/DAB
Registration Deadline
March 26, 2017